Zhengfu He

Dr. Zhengfu He


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
QCQiaofen Chen
Qiaofen Chen
ZCZhao Chen
Zhao Chen
DLDong Liu
Dong Liu
ZHZhengfu He
Zhengfu He
Jianmin WuJianmin Wu
Jianmin Wu

13 April 2022 in ACS Nano
Verified
Journal Article
Closed access
XLXingyue Liu
Xingyue Liu
ZCZhao Chen
Zhao Chen
TWTao Wang
Tao Wang
XJXinrong Jiang
Xinrong Jiang
XQXuetong Qu
Xuetong Qu
Jianmin WuJianmin Wu
Jianmin Wu

23 November 2020 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
QZQingxin Zeng
Qingxin Zeng
ZZZiyi Zhu
Ziyi Zhu
LSLijiang Song
Lijiang Song
ZHZhengfu He
Zhengfu He
The present study aims to investigate the relationship between miR-19b-3p and esophageal cancer (ESCA), and to detect the effects of miR-19b-3p transferred by exosomes on the phenotype of EC9706 cells. The expression of miR-19b-3p was detected by starBase analysis and real-time quantitative PCR (RT-qPCR). The target genes of miR-19b-3p were predicted by TargetScan and further verified by luciferase analysis. The mRNA and protein expression levels of PTEN and EMT-related genes were detected by RT-qPCR and Western blotting. The effects of miR-19b-3p transferred by exosomes and its target genes on the apoptosis, migration and invasion of EC9706 cells were studied by establishing a co-culture model of donor cells. The expression of miR-19b-3p in ESCA plasma, cells and exosomes was significantly up-regulated. miR-19b-3p transferred by exosomes could significantly reduce EC9706 cells apoptosis rate, promote cell migration and invasion, and could target the inhibition of PTEN expression. PTEN overexpression promoted apoptosis, inhibited cell migration and invasion, down-regulated the expression of MMP-2 and vimentin, and up-regulated E-cadherin expression; however, these effects could be partially reversed by miR-19b-3p. In summary, our results reveal that miR-19b-3p transferred by exosomes can target PTEN to regulate ESCA biological functions in the receptor EC9706 cells.

8 April 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
HHHuihui Hu
Huihui Hu
HXHangdi Xu
Hangdi Xu
FLFen Lu
Fen Lu
JZJisong Zhang
Jisong Zhang
LXLi Xu
Li Xu
ZHZhengfu He
Zhengfu He
Objective: This study aimed to describe the mechanism of exosome-derived miR-486-5p underlying the cell cycle and progression in lung adenocarcinoma (LUAD).Methods: Bioinformatics methods were applied for identifying the differentially expressed genes (DEGs) in the GEO-LUAD dataset, predicting where the potential target miRNA was expressed and exploring the corresponding downstream target mRNA. qRT-PCR was conducted to detect the levels of the target genes in cancer cells. Thereafter, a series of in vitro experiments were performed for cell activities evaluation, including CCK-8, EdU, colony formation assay and transwell. Besides, Western blot was applied to determine the protein levels of the migration and invasion-related factors (NEK2, E-cadherin, N-cadherin, Vimentin, MMP-2, and MMP-9). Dual-luciferase reporter gene assay was employed for validating the targeted relationship between the target genes. Furthermore, nude mouse transplantation tumor experiment was conducted to further validate the role of the target miRNA in tumor development, and immunohistochemistry was used for Ki67 detection and TUNEL was applied for cell apoptosis assay.Results: miR-486-5p was observed to be enriched in serum exosomes, and seen to be significantly down-regulated in cancer tissues as well as in cancer serum exosomes. It was proven that exosomes could release miR-486-5p, thus regulating LUAD progression and affecting cell cycle. Moreover, NEK2 was identified as a target of miR-486-5p both in vivo and in vitro. Enrichment analysis revealed that NEK2 was mainly activated in cell cycle and mitosis-related pathways. Meanwhile, NEK2 was found to present significant difference in different TNM stages. Furthermore, rescue experiments indicated that the inhibitory effect of miR-486-5p overexpression on LUAD progression could be abrogated when miR-486-5p and NEK2 were simultaneously up-regulated.Conclusion: Exosome-derived miR-486-5p is responsible for cell cycle arrest as well as the inhibition of cell proliferation and metastasis in LUAD via targeting NEK2.

4 July 2024 in Advanced Science
Verified
Journal Article
Open access
XLXuemei Liu
Xuemei Liu
QCQiaofen Chen
Qiaofen Chen
SXShiyuan Xu
Shiyuan Xu
JWJiaying Wu
Jiaying Wu
JZJingwen Zhao
Jingwen Zhao
Jianmin WuJianmin Wu
Jianmin Wu
Helicobacter pylori (HP), a common microanaerobic bacteria that lives in the human mouth and stomach, is reported to infect ≈50% of the global population. The current diagnostic methods for HP are either invasive, time‐consuming, or harmful. Therefore, a noninvasive and label‐free HP diagnostic method needs to be developed urgently. Herein, reduced graphene oxide (rGO) is composited with different metal‐based materials to construct a graphene‐based electronic nose (e‐nose), which exhibits excellent sensitivity and cross‐reactive response to several gases in exhaled breath (EB). Principal component analysis (PCA) shows that four typical types of gases in EB can be well discriminated. Additionally, the potential of the e‐nose in label‐free detection of HP infection is demonstrated through the measurement and analysis of EB samples. Furthermore, a prototype of an e‐nose device is designed and constructed for automatic EB detection and HP diagnosis. The accuracy of the prototype machine integrated with the graphene‐based e‐nose can reach 92% and 91% in the training and validation sets, respectively. These results demonstrate that the highly sensitive graphene‐based e‐nose has great potential for the label‐free diagnosis of HP and may become a novel tool for non‐invasive disease screening and diagnosis.

1 October 2021 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
CSChangxian Shen
Changxian Shen
YHYuqi He
Yuqi He
QCQiang Chen
Qiang Chen
HFHaihua Feng
Haihua Feng
TWTerence M. Williams
Terence M. Williams
ZHZhengfu He
Zhengfu He
Narrative review of emerging roles for AKT-mTOR signaling in cancer radioimmunotherapy Changxian Shen, Yuqi He, Qiang Chen, Haihua Feng, Terence M. Williams, Yuanzhi Lu, Zhengfu He